Mednax Historical Cash Flow
| MD Stock | USD 14.76 0.20 1.34% |
Analysis of Mednax cash flow over time is an excellent tool to project Mednax Inc future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 32.6 M or Other Non Cash Items of 165.5 M as it is a great indicator of Mednax ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Mednax Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Mednax Inc is a good buy for the upcoming year.
Mednax |
About Mednax Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Mednax balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Mednax's non-liquid assets can be easily converted into cash.
Mednax Cash Flow Chart
Add Fundamental
Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Mednax Inc to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Mednax operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Mednax's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Mednax Inc current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mednax Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. At present, Mednax's Free Cash Flow is projected to decrease significantly based on the last few years of reporting. The current year's Other Non Cash Items is expected to grow to about 165.5 M, whereas Change In Working Capital is projected to grow to (11 M).
Mednax cash flow statement Correlations
Click cells to compare fundamentals
Mednax Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Mednax cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | (145.3M) | (8.5M) | (4.7M) | (88.5M) | (919K) | (965.0K) | |
| Change In Cash | 56.0M | 1.0B | (736.5M) | (377.6M) | 63.4M | 66.6M | |
| Free Cash Flow | 314.8M | 175.8M | 44.5M | 137.2M | 104.0M | 182.0M | |
| Change In Working Capital | 97.2M | 52.7M | (23.4M) | 31.8M | (11.6M) | (11.0M) | |
| Begin Period Cash Flow | 56.7M | 107.9M | 1.1B | 387.4M | 9.8M | 9.3M | |
| Other Cashflows From Financing Activities | 3.5B | 1.1B | 407K | 732K | (10.6M) | (10.1M) | |
| Depreciation | 78.9M | 28.4M | 32.1M | 35.6M | 36.2M | 32.6M | |
| Other Non Cash Items | 1.5B | 57.7M | (27.8M) | 43.6M | 157.6M | 165.5M | |
| Capital Expenditures | 31.9M | 28.8M | 32.2M | 29.7M | 33.3M | 28.1M | |
| Total Cash From Operating Activities | 346.6M | 204.6M | 76.7M | 166.9M | 137.3M | 210.1M | |
| Net Income | (1.2B) | (9.6M) | 108.0M | 62.6M | (60.4M) | (57.4M) | |
| Total Cash From Financing Activities | (393.1M) | (4.2M) | (760.1M) | (487.6M) | (25.7M) | (27.0M) | |
| End Period Cash Flow | 112.8M | 1.1B | 387.4M | 9.8M | 73.3M | 93.5M | |
| Change To Account Receivables | 7.9M | 37.9M | (72.7M) | (5.5M) | 26.3M | 27.6M | |
| Other Cashflows From Investing Activities | 152.7M | 872.7M | 84.9M | (26.8M) | (30.8M) | (32.3M) | |
| Change To Netincome | 1.8B | 912.8M | (14.2M) | 31.4M | 36.1M | 34.3M | |
| Change To Liabilities | 46.2M | 44.5M | (3.5M) | (1.4M) | (1.2M) | (1.2M) | |
| Change To Inventory | 70.3M | (66.7M) | (34.1M) | (54.9M) | (49.4M) | (46.9M) | |
| Stock Based Compensation | 35.4M | 39.0M | 19.0M | 16.1M | 12.3M | 11.7M | |
| Dividends Paid | 2.2B | 1.7B | 526.3M | 470M | 540.5M | 513.5M | |
| Investments | 102.5M | (28.4M) | 1.4M | (57.0M) | (47.0M) | (44.6M) | |
| Net Borrowings | (239.5M) | (1.7M) | (759.8M) | (401.5M) | (361.4M) | (343.3M) | |
| Total Cashflows From Investing Activities | 102.5M | 815.5M | (53.1M) | (57.0M) | (65.5M) | (68.8M) | |
| Change To Operating Activities | (12.6M) | (26.2M) | 30.3M | 18.7M | 21.5M | 22.6M | |
| Issuance Of Capital Stock | 11.3M | 7.0M | 6.9M | 5.4M | 5.1M | 6.9M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mednax Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mednax. If investors know Mednax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mednax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.11) | Earnings Share (2.34) | Revenue Per Share 24.174 | Quarterly Revenue Growth 0.009 | Return On Assets 0.0467 |
The market value of Mednax Inc is measured differently than its book value, which is the value of Mednax that is recorded on the company's balance sheet. Investors also form their own opinion of Mednax's value that differs from its market value or its book value, called intrinsic value, which is Mednax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mednax's market value can be influenced by many factors that don't directly affect Mednax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mednax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mednax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mednax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.